Abstract
Previously, it was found that a novel class of neutral fucosylated glycosphingolipids (GSLs) is required for male fertility. These lipids contain very long-chain (C26-C32) polyunsaturated (4-6 double bonds) fatty acid residues (VLC-PUFAs). To assess the role of these complex GSLs in spermatogenesis, we have now investigated with which of the testicular cell types these lipids are associated. During postnatal development, complex glycosylated and simple VLC-PUFA sphingolipids were first detectable at day 15, when the most advanced germ cells are pachytene spermatocytes. Their synthesis is most likely driven by ceramide synthase-3. This enzyme is encoded by the Cers3/Lass3 gene (longevity assurance genes), and out of six members of this gene family, only Cers3 mRNA expression was limited to germ cells, where it was up-regulated more than 700-fold during postnatal testicular maturation. Increasing levels of neutral complex VLC-PUFA GSLs also correlated with the progression of spermatogenesis in a series of male sterile mutants with arrests at different stages of spermatogenesis. Remarkably, fucosylation of the complex VLC-PUFA GSLs was not essential for spermatogenesis, as fucosylation-deficient mice produced nonfucosylated versions of the complex testicular VLC-PUFA GSLs, had complete spermatogenesis, and were fertile. Nevertheless, sterile Galgt1-/- mice, with a defective meiotic cytokinesis and a subsequent block in spermiogenesis, lacked complex but contained simple VLC-PUFA GSLs, as well as VLC-PUFA ceramides and sphingomyelins, indicating that the latter lipids are not sufficient for completion of spermatogenesis. Thus, our data imply that both glycans and the particular acyl chains of germinal sphingolipids are relevant for proper completion of meiosis.
The testis is composed of two functional compartments as follows: (i) the seminiferous tubules, containing developing germ cells and supporting Sertoli cells, and (ii) the steroidogenic Leydig cells in the interstitium (Fig. 1A) (1, 2). In mature testis, the seminiferous tubules are separated by a blood-testis barrier (BTB)5 into a basal and an adluminal compartment. Tight junctions contribute to the establishment of the BTB, which is made up of adjacent Sertoli cells and physically segregates post-meiotic germ cells from nutrients and biomolecules in the systemic circulation (3, 4).
The development of the male germ cells, taking place within the seminiferous tubules, is a complex and highly regulated process (2). During spermatogenesis, testicular stem cells (undifferentiated spermatogonia) give rise to a lineage of cells that multiply by mitosis (proliferative spermatogonia). These cells differentiate to go through the meiotic division (spermatocytes) and become haploid germ cells (spermatids), which transform into spermatozoa. It is during the meiotic prophase that leptotene spermatocytes transit the BTB. The post-meiotic development (spermiogenesis) involves a dramatic change of nuclear shape, chromatin condensation, the loss of most cell organelles, and the formation of specialized structures, including a flagellum, an acrosome, and a mitochondrial sheath.
In mice, spermatogenesis is dependent on two types of glycolipids, seminolipid, a sulfated galactoglycerolipid (5-7), and glycosphingolipids (GSLs) (8, 9). GSLs are amphipathic cell membrane molecules present on the extracellular leaflet of the plasma membrane lipid bilayers and on topologically equivalent membrane sides of endocytotic and exocytotic organelles (10). They modulate membrane properties and receptors (11, 12) or ion channel functions (6, 13, 14).
Loss of ganglio-series GSLs by systemic deletion of the GalNAc transferase (Galgt1-/-) (Fig. 2) renders male mice sterile. Their spermatogenesis, the transformation of diploid spermatogonial stem cells into haploid spermatozoa, abrogates at the stage of haploid spermatid formation. Spermatogonial stem cell division, proliferation, and differentiation into preleptotene and leptotene spermatocytes appears unchanged. However, after adluminal completion of meiotic karyokinesis, haploid round spermatids aggregate in multinuclear giant cells. Spermiogenesis does not take place in Galgt1-/- mice (8, 15).
Recently, we performed a detailed analysis of GSLs in mouse testis revealing the presence of more than 13 complex neutral and acidic GSLs. Of these GSLs a class of eight fucosylated GSLs (FGSLs) was discovered to contain polyenoic (4-6 double bonds) very long-chain fatty acid residues (C26-C32) in their ceramide moieties (Fig. 2) (9). These structures were also found to be present in rat testis (9). Comparison of infertile Galgt1-/- and fertile Siat9-/- mice, lacking different subsets of GSLs, linked the absence of neutral polyenoic FGSLs to the spermatogenic arrest of meiosis in Galgt1-/- mice suggesting an essential role of polyenoic FGSLs in meiotic and post-meiotic membrane processes (9). Three of the eight FGSLs could be linked to germ cells by immunocytochemistry, with the other five FGSLs still remaining to be localized (9). Two features distinguish the polyenoic FGSLs from conventional GSLs as follows: (i) their fucosylation and (ii) their fatty acid tail being mainly of very long chain and polyenoic. Both structural features could be essential for proper spermatogenesis, which has still to be clarified. In this study we present the following: (i) we classify and localize fucosylated GSLs to different germ cell classes according to their charge; (ii) we demonstrate that polyenoic very long-chain fatty acid-containing sphingolipids in general (FGSLs, GSLs, ceramides, and sphingomyelins) are restricted to germ cells and are expressed in a differentiation stage-specific manner (Fig. 1B); (iii) we link the synthesis of polyenoic VLCFA sphingolipids to the expression of one of six potential (dihydro)ceramide synthases; and (iv) we show the dispensability of sphingolipid fucosylation for the generation of functional spermatozoa.
EXPERIMENTAL PROCEDURES
Mice—Postnatal lipid analysis (P5-P35) was performed from testes of C57BL/6 mice obtained from Charles River WIGA (Deutschland) GmbH, Sulzfeld, Germany. The following mutant mice were analyzed: Slc35c1-/- (16), Galgt1-/- (15), and KitW-v/KitW (Jax Stock number 100410; 6-8 weeks old), mshi/mshi (mshi indicates male sterility and histoincompatibility; number 002169), and bax-/- (number 002994; 6-8 weeks old) were obtained from The Jackson Laboratory, Bar Harbor, ME. Testes from CREM-/- mice (8-16 weeks old) were provided by Paolo Sassone-Corsi (Institut de Génétique et de Biologie Moléculaire et Cellulaire, Strasbourg, France), and XXSxrb mice (8-12 weeks old; where XXSxrb indicates male mice with two copies of the X chromosome that contains the Sxrb region) were provided by Paul Burgoyne (MRC National Institute for Medical Research, London, UK).
GSL Extraction for TLC and ESI-MS/MS Analysis—GSLs were extracted from testes according to Ref. 17. In brief, tissue was homogenized on ice, lyophilized, and extracted twice with dry acetone. The residual pellet then was extracted twice with chloroform/methanol/water (C/M/W) (10:10:1) and with C/M/W (30:60:8). The combined C/M/W extracts were treated with 0.1 m methanolic KOH for 2 h at 37 °C, neutralized with acetic acid, and desalted with RP-18 column chromatography. Finally, neutral and acidic sphingolipids were separated on DEAE A-25 columns, and both were desalted again using RP-18 columns.
TLC Analysis—TLC analysis was performed according to Ref. 17. TLCs were developed with the solvent system CHCl3, CH3OH, 0.2% aqueous CaCl2 = 60:35:8. Staining was performed with orcinol/sulfuric acid.
Nano-electrospray Ionization-Tandem Mass Spectrometry—Analysis was performed with a triple quadrupole instrument (VG Micromass (Cheshire, UK) model Quattro II) equipped with a nano-electrospray source and gold-sputtered capillaries as described (17). Parameters for cone voltage and collision energy of the different scan modes were used, and quantification of sphingolipids was performed according to previous publications (9, 17-19).
HPLC Analysis of GSLs—Extracted GSLs were digested with ceramidase, and the sugar moiety was purified and covalently linked to a fluorophore (anthranilic acid). The fluorescent sugar moieties then were separated and quantified using HPLC as described previously (20).
Histology—Serial semithin Epon sections (0.5-1 μm in thickness) were carried out as described previously (21). In brief, mice were anesthetized by a combination of ketamine and xylazine and subsequently perfused via either the left ventricle or the abdominal aorta. The fixative used for perfusion contained 1.5% paraformaldehyde, 1.5% glutaraldehyde, 2.5% polyvinylpyrrolidone dissolved in 0.1 m phosphate-buffered saline, pH 7.4. Organs were removed and 80-200 μm thick sections prepared by using a Dosaka microslicer. The sections were postfixed with 1.5% osmium ferrocyanide followed by 1.5% buffered osmium tetroxide. The samples were then stained en bloc with 1% uranyl acetate and processed for Epon embedding. Serial semithin sections (0.5-1 μm) were stained with a modified Richardson solution (methylene blue-Azur II).
Quantitative RT-PCR—Total mRNAs from juvenile and pubertal testes were isolated according to Chomczynski et al. (22). Testicular mRNAs from mutant/genetically modified mice were extracted using TRIzol reagent (Invitrogen) following the manufacturer's instructions. RNA quality was characterized using an RNA6000 Nanochip (Agilent Technologies, Waldbronn, Germany). Isolated mRNA was digested with TURBO DNA-free™ kit (Ambion) to remove DNA contamination. Double-stranded cDNA was synthesized using the SuperScript™ double-stranded cDNA synthesis kit (Invitrogen) as described by the manufacturer. For quantification of cDNA, real time PCR was performed by LightCycler® (System 2.0, Roche Diagnostics) using LightCycler-FastStart DNA MasterSYBR Green I kit (Roche Diagnostics) as described (23). Melting curves were performed to evaluate the integrity of the products. Relative expression of the Cers/Lass family genes was determined using the comparative CT method, normalizing relative values to the expression of GAPDH as a housekeeping gene (24). The primer sequences for target genes are listed in Table 1.
TABLE 1.
Gene | Primer | Primer sequence | Product size |
---|---|---|---|
bp | |||
Gapdh | Forward | 5′-ACT CCC ACT CTT CCA CCT TC-3′ | 156 |
Reverse | 5′-GGT CCA GGG TTT CTT ACT CC-3′ | ||
Cers1 | Forward | 5′-TGA CTG GTC AGA TGC GTG A-3′ | 93 |
Reverse | 5′-TCA GTG GCT TCT CGG CTT T-3′ | ||
Cers2 | Forward | 5′-TCA TCA TCA CTC GGC TGG T-3′ | 90 |
Reverse | 5′-AGC CAA AGA AGG CAG GGT A-3′ | ||
Cers3 | Forward | 5′-ATC TCG AGC CCT TCT TCT CC-3′ | 128 |
Reverse | 5′-CTG GAC GTT CTG CGT GAA T-3′ | ||
Cers4 | Forward | 5′-TGC GCA TGC TCT ACA GTT TC-3′ | 132 |
Reverse | 5′-CTC GAG CCA TCC CAT TCT T-3′ | ||
Cers5 | Forward | 5′-TCC ATG CCA TCT GGT CCT A-3′ | 147 |
Reverse | 5′-TGC TGC CAG AGA GGT TGT T-3′ | ||
Cers6 | Forward | 5′-GGG TTG AAC TGC TTC TGG TC-3′ | 138 |
Reverse | 5′-TTT CTT CCC TGG AGG CTC T-3′ |
RESULTS
Seminiferous Tubules of KitW-v/KitW Mice Contain Mainly Sertoli Cells and a Residual Number of Spermatogonial Stem Cells—KitW-v/KitW mice lack the receptor c-kit, which is expressed from the differentiating type A spermatogonia through the pachytene spermatocytes. Without stimulation of c-kit by its ligand, stem cell factor, differentiated type A spermatogonia and subsequent germ cell stages are lost. All other testicular cell types are maintained (25). Light microscopy analysis of semithin Epon sections of seminiferous tubules of KitW-v/KitW mice revealed the complete absence of spermatocytes and spermatids. The atrophic tubules contained mainly Sertoli cells but also a residual undifferentiated type A spermatogonial compartment, in agreement with previous reports (25). Both differentiating spermatogonia and Sertoli cells undergo apoptosis (Fig. 3, A and B for overview see also supplemental Fig. 1, A and B).
“Germ Cell-free” Testes (KitW-v/KitW Mice) Lack Polyenoic Sphingolipids—To distinguish which of the testicular GSLs are associated with germ cells (except from residual spermatogonia), sterile germ cell-free KitW-v/KitW and fertile control KitW-v mice were analyzed by TLC. The set of neutral FGSLs was lacking and the set of acidic FGSLs was reduced in KitW-v/KitW testes. Bands due to nonfucosylated GSLs such as Forssman lipid, GM3, GM2, GD1a, GT1b, and GQ1b appeared to be not altered or slightly enhanced (Fig. 3E). Whereas neutral FGSLs were reported previously to contain almost exclusively VLC-PUFAs, fucosylated gangliosides also contain to a significant degree palmitic acid (C16:0) (9). Therefore, GSLs of mutant and control testes were further compared by electrospray tandem mass spectrometry: signals corresponding to complex VLC-PUFA containing neutral GSLs (IV2-α-Fuc-GA1, IV3-α-Gal, IV2-α-Fuc-GA1, IV3-α-GalNAc, IV2-α-Fuc-GA1, and IV3-α-GalNAcβ3Gal, IV2-α-Fuc-GA1) and VLC-PUFA gangliosides (IV3-α-Gal, IV2-α-Fuc-GM1a, IV3-α-GalNAc, IV2-α-Fuc-GM1a, and IV3-α-GalNAcβ3Gal,-IV2-α-Fuc-GM1a) were not detectable in KitW-v/KitW testes. Signals corresponding to VLC-PUFA FucGM1 could be detected in control mice after elimination of GD1 signals by prior digestion of the sample with sialidase from Vibrio cholerae. These signals were not present in the testis of KitW-v/KitW mice (data not shown). Taking the detection limits into account, signals for the major VLC-PUFA FGSLs, VLC-PUFA IV2-α-Fuc-GA1 (FucGA1), were reduced in KitW-v/KitW testes to at least 1% as compared with control testes. As the remaining FGSLs, only IV2-α-Fuc-GM1a (FucGM1) containing a saturated long-chain fatty acid moiety, palmitic acid, could be detected in KitW-v/KitW testes and appeared to be reduced (Fig. 3, C and D). In adult mice, FucGM1 is localized mainly in spermatogonia but not in differentiating spermatocytes (9). By quantitative HPLC analysis of derivatized GSLs according to Neville et al.6 (20), neutral FGSLs were undetectable, whereas all four fucosylated acidic GSLs (gangliosides) were detectable but were 50-75% lower in KitW-v/KitW testis as compared with controls (Fig. 6, D and E). The latter represented the fraction with long-chain saturated but not very long-chain polyunsaturated fatty acid moieties. Further quantitative mass spectrometric analysis of GlcCer and the nonglycosylated sphingolipids ceramide and sphingomyelin revealed that the subsets of these sphingolipids that contain VLC-PUFAs were absent from KitW-v/KitW testes (Fig. 3F).
The Expression of Cers3 mRNA, Encoding a Dihydroceramide Synthase, Is Lost in Germ Cell-free Testes (KitW-v/KitW-v Mice)—Fatty acids are transferred to sphingoid bases by a family of (dihydro)ceramide synthases (CerS) encoded by the genes Cers1-6 formerly known as longevity assurance genes (Lass). To find the CerS potentially responsible for the incorporation of VLC-PUFAs into sphingolipids, testicular mRNA levels of all six Cers genes were determined in KitW-v/KitW and corresponding control mice by quantitative real time PCR (qRT-PCR). In control mice, the levels of Cers mRNAs could be ranked as Cers3 > Cers5 and Cers2 > Cers6. Cers1 and Cers4 mRNA were barely detectable. In KitW-v/KitW testes, the level of Cers3 mRNA was over 150-fold decreased, to 0.6% of control value. Cers5, Cers6, and Cers2 mRNAs could also be detected in the germ cell-free testes; their levels were 80, 45, and 20% of control values, respectively (Fig. 3G). Taking the overall decrease of Cers mRNAs in KitW-v/KitW testes into account, the only significant decrease that could be responsible for the complete loss of VLC-PUFA sphingolipids was that of Cers3 mRNA.
During the First Wave of Spermatogenesis Polyenoic Sphingolipids Appear Around Postnatal Day 15/16—Having studied the GSL composition of germ cell-free testes (see above) and those of normal testes (with a full germ cell complement), we monitored the expression of VLC-PUFA glycosphingolipids in the testes during the first wave of spermatogenesis. During this phase of development, the germ cell complement of the testes gradually expands from exclusively spermatogonial precursor cells (gonocytes, at postnatal day 6) to the full range of germ cells, including the first spermatozoa (postnatal day 30-35). Over this time the germ cells develop in a synchronized fashion, offering an opportunity to identify at which developmental step germ cells first express the VLC-PUFA sphingolipids. The postnatal germ cell development has been described in detail (26-28). Briefly, seminiferous tubules of newborn mice contain only Sertoli cells and gonocytes, which turn into spermatogonia that subsequently proliferate and differentiate into spermatocytes and spermatids. At 10 days of age meiotic prophase is initiated, and predominantly preleptotene and leptotene primary spermatocytes are visible (Fig. 4A, for an overview see supplemental Fig. 2). At P14, spermatocytes of mainly leptotene, zygotene, and pachytene stages are found, and at P15 spermatocytes of pachytene stage are present in most tubules (Fig. 4, B and C). Between P16 and P18, the functional maturation of Sertoli cells and the blood-testis barrier are established (supplemental Fig. 3). At P20 most seminiferous tubules contain large numbers of pachytene spermatocytes, and some round spermatids are found (Fig. 4D). At P30 the number of round spermatids enlarges, and 50% of the tubules also contain elongating spermatids (supplemental Fig. 2).
TLC analysis and HPLC quantification revealed that the subset of neutral FGSLs, essential for spermatogenesis beyond the stage of round spermatids, was absent before day P15 but became the major neutral GSL fraction by P20. The simple gangliosides GM3 and GD3, which are faint or not detectable in adult testis, were strongly expressed before P15. After P10, levels of GM3 and GD3 decreased, changing inversely in relation to the amounts of neutral FGSLs (Fig. 4, E and F, and supplemental Fig. 4).
The content of VLC-PUFAs in sphingolipids (GSLs, ceramide, and sphingomyelin) was also analyzed by mass spectrometry. All GSLs, including the fucosylated gangliosides, ceramides, and sphingomyelins present before day P15 had long-chain but not very long-chain fatty acid length (C16-C24), and their fatty acids were saturated (C16:0 -C24:0) or monounsaturated (C24: 1). Palmitic acid was the major fatty acid of sphingolipids before day P15 (supplemental Figs. 5 and 7). Small amounts of VLC-PUFA Cer, VLC-PUFA SM (Fig. 4G), and VLC-PUFA GSLs (supplemental Fig. 5) could be detected at P15. Within the next 5 days, VLC-PUFA Cer and SM increased conspicuously. At P20, the VLC-PUFA Cer concentration was at the same level as at P35, whereas VLC-PUFA SM reached a maximum at P25 and remained at this level to P35 (Fig. 4G). At the latter time point, the combined concentration of VLC-PUFA Cer and VLC-PUFA SM (30 pmol/mg tissue wet weight) was similar to that of the VLC-PUFA GSLs.
Cers3 Is Up-regulated during Juvenile Testicular Maturation—To establish whether any of the ceramide synthases could be linked to the rise in VLC-PUFA GSLs taking place from day 14/15, levels of Cers mRNAs were analyzed by qRT-PCR in testes of P5 to P25 mice. In the early development prior to P15, Cers5 was the most abundant Cers mRNA in testes followed by 2-6 times lower amounts of Cers2 and Cers6 mRNA. No significant levels of Cers4 and Cers1 mRNAs could be detected. After an initial increase between P5 and P10, Cers5 mRNA levels stayed roughly constant, similar to Cers1, -2, -4, and -6. In contrast, Cers3 mRNA was more than 700-fold up-regulated from P5 to P25. Although hardly detectable at P5, significant amounts of Cers3 mRNA appeared at P14 that 24 h later reached similar levels to Cers5 mRNA and further increased to 2.5-fold the amount of Cers5 mRNA at P25 (Fig. 4H). Thus, the increase in VLC-PUFA GSLs, taking place from postnatal day 14-25, coincided with a strong elevation of Cers3 mRNA.
In Adult Testes, the Levels of Neutral Fucosylated GSLs Correlate with the Progress of Spermatogenesis—To complement the analysis of testicular sphingolipids during postnatal development, we studied testes from mutant and genetically engineered adult mice that have arrests at different steps in spermatogenesis. We have used the testes from XXSxrb and mshi mutant mice and from bax- and CREM-deficient mice. XXSxrb mice have a failure of spermatogonial mitosis. Besides Sertoli cells, their seminiferous tubules contain only early spermatogonia and closely resemble those of KitW-v/KitW mice, except that seminiferous tubules of XXSxrb mice have rare small foci of further germ cell development to the spermatocyte stage (early pachytene) (29). mshi mice have reduced numbers of spermatogonia and spermatocytes; the latter fail to complete the meiotic phase (30). Bax-deficient mice accumulate atypical premeiotic germ cells, whereas small numbers of germ cells complete meiotic karyokinesis and then remain as multinuclear giant cells containing the nuclei of round spermatids (31). CREM-deficient mice display a postmeiotic arrest at the first step of spermiogenesis (32, 33). When ranking this set of testes relative to the extent to which they support spermatogenesis (XXSxrb - Mshi - Bax-/- - CREM-/-), we observed an increase in the percentage of neutral fucosylated GSLs (Fig. 5B and Table 2) and a decrease of neutral nonfucosylated GSLs (Fig. 5D). In contrast, the relative levels of gangliosides were not correlated with the progression of spermatogenesis, irrespective of their fucosylation (Fig. 5, C and E). Thus, also in adult testes the progression of germ cells through meiosis was correlated with high levels of neutral fucosylated GSLs. The GSL profile of the CREM-/- testes was comparable with that of control testes (Fig. 5, B-E, and Table 2). The concentration of the corresponding acidic monosialo-FGSLs did not correlate with progressing spermatogenesis, confirming their main presence in spermatogonia (Fig. 5C and Table 2) (9).
TABLE 2.
Mouse model
|
Spermatogenesis arrest at stage(s)
|
Neutral GSLs
|
Anionic GSLs
|
||||
---|---|---|---|---|---|---|---|
Nonfucosylated | Fucosylated | Nonfucosylated | Fucosylated + GD1a | ||||
% | % | ||||||
XXSxrb | Spermatogonia | 79.0 ± 6.5 | 8.7 ± 1.7 | 34.9 ± 2.0 | 42.1 ± 2.7 | ||
mshi | Spermatogonia/spermatocytes | 70.4 ± 2.1 | 19.5 ± 2.0 | 27.3 ± 3.2 | 59.2 ± 2.0 | ||
bax−/− | Spermatogonia/spermatids | 50.3 ± 2.2 | 45.7 ± 6.4 | 36.2 ± 5.6 | 50.7 ± 5.1 | ||
CREM−/− | Early spermatids | 11.6 ± 0.6 | 86.3 ± 0.9 | 37.0 ± 4.6 | 48.3 ± 6.1 | ||
C57BL/6 | None | 05.1 ± 0.7 | 93.7 ± 0.4 | 25.9 ± 4.7 | 55.8 ± 6.8 |
Infertile Galgt1-/- Mice Lacking Fucosylated Complex Ganglio-series GSLs Still Contain VLC-PUFA Ceramides, Sphingomyelins, and Lactosylceramides—Sterile GalNAc transferase-deficient (Galgt1-/-) mice have an arrest in spermatogenesis after adluminal completion of meiotic karyokinesis (Fig. 6, A and B) and lack complex ganglio-series GLSs, including VLC-PUFA FGSLs (9). To further delineate whether these mice are sterile because of the complete loss of VLC-PUFA sphingolipids, we analyzed the simple sphingolipids Cer, SM, GlcCer, and LacCer in addition to the FGSLs with respect to their acyl chains. As expected from previous TLC and MS data (9), HPLC analysis confirmed the lack of all neutral FGSLs, similar to the germ cell-deficient KitW-v/KitW mice (Fig. 6D). However, the Galgt1-/- testes were comparable with control (Galgt1+/-) testes, in that they contained “simple” VLC-PUFA sphingolipids, albeit in different amounts. They had 60% less VLC-PUFA sphingomyelins and 9 times more VLC-PUFA LacCer, the biosynthetic precursor of VLC-PUFA FGSLs. On a molar basis this increase corresponded to the amount of the VLC-PUFA FGSLs that were lacking. No significant changes were found in the composition of VLC-PUFA ceramides and VLC-PUFA GlcCers (Fig. 6C).
Fucosylation of Germ Cell GSLs Is Not Essential for Fertility and Spermiogenesis—To investigate the significance of the fucosylation of the neutral VLC-PUFA GSLs, we studied the GSLs from mice lacking the transporter responsible for the import of GDP-fucose into the Golgi (Slc35c1-/-). These mice have a profound reduction of fucosylated glycoconjugates in tissues and isolated cells. Although showing severe growth retardation and a shortened life span, male Slc35c1-/- mice are fertile (16). Histological analysis of testes revealed no significant changes in the seminiferous epithelium demonstrating normal spermatogenesis/spermiogenesis (Fig. 7, A and B). The testes of these mice did not contain any fucosylated GSLs. All eight GSLs that are fucosylated in control testes were expressed in Slc35c1-/- testes without fucosylation, but they still contained VLC-PUFAs to a similar extent as in controls (Fig. 7, C and D).
DISCUSSION
By elucidating and comparing testicular GSL profiles of infertile Galgt1-/- and fertile Siat9-/- mutants with control mice, it was previously shown that complex neutral FGSLs containing VLC-PUFAs (more than 24 carbon atoms and 4-6 double bonds) appeared to be essential for spermatogenesis to proceed beyond the formation of round spermatids. Two of the four neutral FGSLs, FucGA1 and GalNacGal(Fuc)GA1, had been linked by immunocytochemistry to adluminal spermatocytes and spermatids. One of the four corresponding acidic FGSLs, FucGM1, was localized in spermatogonia but not in spermatocytes (9). As this class of FGSLs is distinguishable from the other 13 testicular neutral and acidic GSLs by the incorporation of VLC-PUFAs into their ceramide moieties, we suggested that all of them are expressed by germ cells. To test this hypothesis, we investigated testes of KitW-v/KitW mice, lacking differentiating germ cells. The histological analysis revealed that testes of these mice still contain some undifferentiated type A spermatogonia, which upon differentiation underwent apoptosis. Therefore, no intact spermatocytes or spermatids were detectable, confirming previous findings (25). Testicular lipid analysis revealed that all neutral GSLs, and a major portion of the acidic fucosylated GSLs, were absent from KitW-v/KitW testes with all other GSLs still remaining. Moreover, no mass spectrometric signal for any kind of GSLs containing VLC-PUFAs could be detected in KitW-v/KitW testes. The mutant testes also lacked VLC-PUFA ceramides and sphingomyelins, which were present at relatively high levels in control testes (ceramide is the precursor of GSLs as well as of sphingomyelin). Thus, taking into account the previous immunohistochemical evidence and the current results, it appears that the expression of fucosylated GSLs is restricted to germ cells. Fucosylated gangliosides with longchain fatty acids are already present in spermatogonia, whereas both neutral and anionic fucosylated GSLs having VLC-PUFAs emerge later during differentiation. Therefore, our findings indicate that the expression of sphingolipids containing VLC-PUFAs is basically restricted to differentiating germ cells (Fig. 1B).
To find out at which stage differentiating germ cells start to synthesize GSLs with VLC-PUFAs, testicular sphingolipids were analyzed at different time points within the first wave of spermatogenesis (postnatal day 6-35). Until 14 days after birth no VLC-PUFA sphingolipids (PUSLs) could be detected, with PUSL traces appearing at 15 days after birth (Cer, SM, and FGSLs). This correlates with the appearance of pachytene spermatocytes and is also about the time point of BTB establishment by functionally maturing Sertoli cells (Fig. 1B). The BTB, with its tight junction complexes, creates a distinct milieu for differentiating germ cells to complete meiosis and spermiogenesis in the adluminal compartment of the seminiferous tubules. The adluminal milieu could be a factor promoting the expression of PUSLs. Although PUSLs are increasing during the first wave of spermatogenesis, GlcCer, GM3, and GD3, containing mainly palmitic acid, markedly decrease. The latter GSLs appear to be present in somatic testicular cells, which do not change significantly in cell number during testicular maturation. Thus, the abundance of GlcCer, GM3, and GD3 among testicular cells decreases as the number of germ cells in the testis increases during postnatal development (see supplemental Fig. 2).
While investigating adult mutant and genetically engineered mice with spermatogenesis arrests, we found a direct correlation between the amount of testicular neutral FGSLs and the extent to which spermatogenesis proceeded in these mice. This is in agreement with the generation of fucosylated VLC-PUFA GSLs together with the appearance of pachytene spermatocytes during testicular maturation, and it rules out that somatic testicular cells switch on VLC-PUFA sphingolipid synthesis upon testicular maturation.
Our findings are in agreement with reports on testicular VLC-PUFA ceramides and sphingomyelins obtained from other mammalian species, including rats, as published recently by Furland et al. (34, 35). Although their results point to a role of polyenoic ceramides and sphingomyelins in sperm capacitation, our results accentuate the importance of polyenoic GSLs early in spermatogenesis.
In the testes from infertile Galgt1-/- mice, spermatogenesis arrests at the stage of round spermatids that aggregate to form multinuclear giant cells. We show that ceramides, sphingomyelins, GlcCers, and LacCers with VLC-PUFAs are present in the Galgt1-/- testis. VLC-PUFA ceramide and VLC-PUFA GlcCer levels did not differ from control values. Importantly, the sphingolipid metabolism is disturbed in three ways in the testes from the mutant mice. First, all GSLs that are synthesized by GalNAc transferase are absent, including the polyenoic complex glycolipids. Second, levels of VLC-PUFA sphingomyelins were decreased; and third, VLC-PUFA LacCer levels were much higher than in control testes. Taking all these alterations in sphingolipid metabolism in Galgt1-/- testis into account, it is essential to distinguish which of the lipid abnormalities is responsible for the impairment of spermatogenesis in the mutant testes.
In Galgt1-/- testis, the changes in VLC-PUFA sphingomyelins and LacCer are unlikely to be the cause of the arrest in spermatogenesis. It is rather more plausible that the lack of neutral VLC-PUFA GSLs with complex glycosylation leads to the impairment of germ cell development. Arguments for this are the following. (i) In DBA2 mice, treatment with N-butyldeoxynojirimycin (an inhibitor of the non-lysosomal glucosylceramidase GBA2) leads to a significant reduction of VLC-PUFA sphingomyelins but not to an arrest of spermatogenesis (36). (ii) Sphingomyelin synthase 2 is localized in rat testis with late round and elongating spermatids but not to spermatocytes (37). (iii) During the first wave of spermatogenesis, VLC-PUFA ceramide levels reach adult levels before elongating spermatids are found (P20), whereas VLC-PUFA sphingomyelins reach adult level 5 days later (Fig. 4G). (iv) DBA2 mice have very high levels of LacCer in many tissues, including testes,7 but they are normally fertile.
We also have investigated whether fucosylation of germ cell GSLs is required for spermatogenesis. Investigation of mice lacking the Golgi transporter for GDP-Fuc indicates that this is not the case. These mice express complex VLC-PUFAs GSLs in their testes, simply without fucosylation (e.g. GA1 instead of FucGA1 etc.). In addition, these mice appear to have normal spermatogenesis, as judged from the histological analysis of their testes. Furthermore, offspring were successfully obtained from homozygote male and female (Slc35c1-/-) breeding pairs (16).
Currently, we hypothesize that a combination of the polyenoic ceramide-anchor together with a complex carbohydrate structure, containing at least the GA2-sugar moiety, could be essential for preventing male infertility of Galgt1-/- mice. To prove this, analysis of mice with cell type-specific deletions in germ cells of either GSLs or the VLC-PUFA properties of the ceramide-anchor will be necessary.
Understanding PUSL biosynthesis at a molecular level is a prerequisite to address functional studies involving the modulation or deletion of testicular PUSL synthesis. Therefore, we aimed to identify the gene encoding the enzyme responsible for the incorporation of very long-chain polyunsaturated fatty acids into sphingolipids. The condensation of acyl-CoAs with sphinganine (and/or sphingosine) is catalyzed by a family of six (dihydro)ceramide synthases (CerS1-6). In vitro studies revealed differential substrate specificities of the six different mouse CerSs. CerS3 has been reported to be specifically expressed in testis on mRNA levels, and the authors found a rather unspecific affinity of CerS3 for acyl-CoAs. Acyl-CoAs investigated ranged in length from C16 to C26 and were all saturated (38). Unsaturated or testis-specific very long-chain polyunsaturated acyl-CoAs ((h)C28-32:4-6) still remain to be added to these investigations.
Using qRT-PCR, we found Cers2, -3, -5, and -6 mRNAs to be expressed in testis. In adult testis Cers3 expression was highest followed by Cers, whereas in infantile testis (P5-P14) Cers5 expression was highest. CerS5 and CerS6 (Cers5 and -6) preferentially transfer palmitic acyl to sphingoid bases (39, 40), and CerS2 (Cers2) shows a preference for C22/24-chain length acyl-CoAs (40). The mRNA of all these three CerSs are expressed before P14 and do not increase later during testis maturation. Furthermore, Cers2, -5, and -6 mRNAs were the only ones present in germ cell-free testes, which do not express VLC-PUFA sphingolipids. This correlates with sphingolipids containing mainly palmitic acid and some behenic (C22) and lignoceric (C24) acid moieties to be found before P14 and in germ cell-free (KitW-v/KitW) testes. Cers3 mRNA expression, in contrast to the other Cers mRNAs, is lost together with VLC-PUFA sphingolipid expression in mouse testes, which do not contain differentiating germ cells (KitW-v/KitW). Furthermore, Cers3 is the only Cers that is significantly up-regulated between P10 and P20, when PUSLs appear. Therefore, we link testis CerS3 to the synthesis of sphingolipids specifically containing VLC-PUFAs.
Although we could detect minor amounts of VLC-PUFAs (28:5) already at P6 and P10, when no incorporation of these fatty acids into sphingolipids is found, testicular VLC-PUFA levels increase strongly from P15 to P20 in parallel to VLC-PUFA sphingolipid expression (supplemental Fig. 6). The minor amounts found before P15 may be linked to low incorporation into glycerophospholipids, which also at P25 show only minor incorporation of VLC-PUFAs (supplemental Fig. 7). Hence, VLC-PUFA sphingolipid expression in testis probably is a matter of both CerS3 expression and substrate availability. In parallel to the tremendous increase of Cers3 mRNA around P15, the mRNAs of Elovl2 and Elovl5, encoding two acyl-malonyl-acyltransferases of the “elongation of very long chain fatty acids” family, increase from P10 to P25 by 5-7-fold (supplemental Fig. 8). Each of them alone or both together may be responsible for the enhanced production of VLC-PUFAs in testis. Enhanced VLC-PUFA synthesis may also be supported by roughly a 4-fold higher mRNA expression from P10 to P25 of Δ6-fatty acid desaturase, which is needed for the desaturation of ω-6 tetracosatetraenic acid (Δ9,12,15,18-24:4) to ω-6 tetracosapentaenic acid (Δ6,9,12,15,18-24:5) (supplemental Fig. 8).
We think it is unlikely that CerS2, -5, or -6, with its mRNAs present at all time stages, synthesize a majority of VLC-PUFA sphingolipids simply because the VLC-PUFA substrates are becoming available; (i) CerS2, -5, or -6 have been characterized to use acyl-CoAs with the length of 16/(18) (CerS5 and -6) or 22/24 carbon atoms (CerS2) in length. If they would in addition have affinity for very long acyl-CoAs (≥28) no matter if saturated, polyunsaturated or hydroxylated, we would assume that they would also have a similar affinity for fatty acids with a length of 26 carbon atoms ((h)26:0-5). But these fatty acids with the length of 26 carbon atoms (26:0, h26:0, 26:4 and 26:5) are not incorporated to a significant degree into sphingolipids, although they are found in relevant amounts (supplemental Fig. 6). (ii) The characterized substrate of CerS2 (40), lignoceric acid (24:0), is not found in fucosylated sphingolipids nor tetracosatetraenic and -pentaenic acid (24:4-5). But these fatty acids (24:0,4-5) are found in testis at all time stages in higher concentrations than the corresponding VLC fatty acids (≥28) (supplemental Fig. 6). So, unless CerS2, -5, and -6 would have a much higher affinity for VLC-PUFA-CoAs than for docosanoic (22:0), tetracosanoic (24:0), or palmitic acid (16:0), respectively, there must be another CerS responsible for VLC-PUFA sphin-golipid synthesis, CerS3.
We cannot exclude that, as reported, CerS3 has a “relatively broad substrate specificity” with similar affinities for all acylchain lengths. Nevertheless, neutral FGSLs of mouse germ cells contain almost exclusively (hydroxy) very long-chain polyunsaturated fatty acids (C26 -C32:4-6), with the two fatty acids h28:5 and h30:5 being prominent. Only minor amounts of neutral FGSLs with palmitic (C16:0) or hydroxypalmitic acid moieties and no FGSLs with fatty acid moieties in the length range of 18 up to 24 carbon atoms were found. At the same time, germ cells contain significant amounts of long-chain saturated fatty acids (C16-C24) (41) and incorporate high amounts of palmitic acid, particularly into seminolipid (42-44). Thus, out of an acyl-CoA pool containing a larger variety of fatty acids, differentiating germ cells incorporate VLC-PUFAs into (G)SLs with high selectivity. As in vitro findings not always mirror in vivo situations, this selectivity may be achieved by CerS3 itself. The presence of decent amounts of tetracosapentaenic (24:5) and hexacosapentaenic acid (26:5) in testis (supplemental Fig. 6), which are not found to be incorporated to the same degree as VLC-PUFAs into sphingolipids, implies that CerS3 could have a significant affinity for (polyunsaturated) acyl-CoAs with 28 or more carbon atoms but not for (polyunsaturated) acyl-CoAs with 26 or less carbon atoms in length. Alternatively, CerS3 principally could have a broad substrate acceptance, and the specific incorporation observed in testis may be regulated through unknown co-factors, building up a testis-specific enzymatic complex with CerS3.
In conclusion our analytical data indicate that VLC-PUFA GSL with a minimal GA2 core structure are essential for complete spermatogenesis, as we have shown the following. (i) Sterile Galgt1-/- mice contain only simple VLC-PUFA sphingolipids (Cer, SM, GlcCer, and LacCer). (ii) Fucosylated GSLs are restricted to germ cells, with their gangliosides expressed mainly in spermatogonia/basal germ cells and their neutral equivalents from the stage of pachytene spermatocytes and beyond. (iii) PUSLs are expressed in differentiating spermatocytes and spermatids from the stage of pachytene spermatocytes. (iv) PUSL expression is regulated by the germ cell stage-dependent expression of the (dihydro)ceramide synthase CerS3. (iv) Fucosylation of germ cell GSLs is not essential for spermatogenesis and fertility.
Currently we suggest that early germ cells, before they pass the blood-testis barrier, synthesize fucosylated gangliosides and simple sphingolipids with long-chain (C16) saturated fatty acid moieties. Passing the BTB and entering the adluminal compartment, differentiating germ cells switch to the production of almost exclusively PUSLs. The production of fucosylated GSLs increases and a relative drop in sialylation activity occurs, thereby leading to mainly neutral FGSLs, which almost exclusively contain VLC-PUFAs. This is corroborated by the increasing mRNA expression of Galgt1, fucosyltransferase 1 and 2, whereas Siat9 mRNA levels stay constant (supplemental Fig. 8).
Thus, the biosynthesis of PUSLs, including complex GSLs, is initiated during the prophase of meiosis I. However, in the final step of meiosis II, after completion of karyokinesis, the clonal spermatid syncytium with its intercellular bridges is not maintained in infertile Galgt1-/- mice lacking only the complex GSLs. Thus, we conclude that VLC-PUFA complex GSLs appear to play an essential role in the special membrane processes required for maintenance of intercellular bridges, and/or initiation of spermiogenesis, and establishment of Sertoli cell-spermatid interactions.
Supplementary Material
Acknowledgments
We thank Ingrid Kuhn-Krause and Mahnaz Bonrouhi for expert technical assistance. We acknowledge Paolo Sassone-Corsi and Paul Burgoyne, who provided testes from CREM-/- and XXSxrb mice, respectively. We are grateful to Britta Brügger for making the triple Quadrupole nanoESI-MS/MS available to us. Pre-experiments for RT-PCR were performed with published primers (45) obtained from Tony Futerman.
This work was supported, in whole or in part, by National Institutes of Health Grant 1 U01 HD45861 (to A. C. S. and F. M. P.). This work was also supported by the German Research Foundation Grants SA 1721/1-1 and GO 432/2-1, Schering AG (to C. C. C.), and the Oxford Glycobiology Institute endowment. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Footnotes
The abbreviations used are: BTB, blood-testis barrier; Bax, BCL2 associated X-protein; BL6, C57BL/6 mouse strain; Cer, ceramide; CerS1-6, ceramide synthase 1-6; CREM, cyclic AMP-responsive element modulator; FGSLs, fucosylated GSLs; GSLs, glycosphingolipids; GlcCer, glucosylceramide; P5-35, postnatal day 5-35; PUSLs, polyunsaturated sphingolipids; Siat9/St3gal5, β-galactoside α-2,3-sialyltransferase 5 (GM3-synthase); SM, sphin-gomyelin; SM4g, seminolipid (GalEAG I3-sulfate); Sxr, sex-reversed factor, which is an extra copy of the testis-determining region of the mouse Y chromosome but without the Y chromosomal gene required for transplantation H-Y antigen expression; VLC-PUFA, very long-chain polyunsaturated fatty acids; HPLC, high pressure liquid chromatography; qRT, quantitative real time PCR; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; PUSL, VLC-PUFA sphingolipids. The glycolipid nomenclature described by Svennerholm (46) and recommended by the IUPAC (Pure Appl. Chem. (1997) 69, 2475-2487).
By this HPLC analysis, GSLs are detected quantitatively without the need of individual GSL standards. However it does not discriminate ceramide compositions of individual GSLs. For the latter, mass spectrometry was performed.
D. A. Priestman, unpublished observations.
References
- 1.Burgos, M. H., Vitale-Calpe, R., and Aoki, A. (1970) in The Testis: Development, Anatomy, and Physiology (Johnson, A. D., Gomes, W. R., and Vandermark, N. L., eds) pp. 551-577, Academic Press, New York
- 2.Russell, L., Ettlin, R. A., Sinha Hikim, A. P., and Clegg, E. J. (eds) (1990) Histological and Histopathological Evaluation of the Testis, pp. 1-38, Cache River Press, Clearwater, FL
- 3.Russell, L. D. (1980) Gamete Res. 3 179-202 [Google Scholar]
- 4.Mruk, D. D., and Cheng, C. Y. (2004) Endocr. Rev. 25 747-806 [DOI] [PubMed] [Google Scholar]
- 5.Fujimoto, H., Tadano-Aritomi, K., Tokumasu, A., Ito, K., Hikita, T., Suzuki, K., and Ishizuka, I. (2000) J. Biol. Chem. 275 22623-22626 [DOI] [PubMed] [Google Scholar]
- 6.Honke, K., Hirahara, Y., Dupree, J., Suzuki, K., Popko, B., Fukushima, K., Fukushima, J., Nagasawa, T., Yoshida, N., Wada, Y., and Taniguchi, N. (2002) Proc. Natl. Acad. Sci. U. S. A. 99 4227-4232 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Zhang, Y., Hayashi, Y., Cheng, X., Watanabe, T., Wang, X., Taniguchi, N., and Honke, K. (2005) Glycobiology 15 649-654 [DOI] [PubMed] [Google Scholar]
- 8.Takamiya, K., Yamamoto, A., Furukawa, K., Zhao, J., Fukumoto, S., Yamashiro, S., Okada, M., Haraguchi, M., Shin, M., Kishikawa, M., Shiku, H., and Aizawa, S. (1998) Proc. Natl. Acad. Sci. U. S. A. 95 12147-12152 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Sandhoff, R., Geyer, R., Jennemann, R., Paret, C., Kiss, E., Yamashita, T., Gorgas, K., Sijmonsma, T. P., Iwamori, M., Finaz, C., Proia, R. L., Wiegandt, H., and Grone, H. J. (2005) J. Biol. Chem. 280 27310-27318 [DOI] [PubMed] [Google Scholar]
- 10.Kolter, T., and Sandhoff, K. (1999) Angew. Chem. Int. Ed. Engl. 38 1532-1568 [DOI] [PubMed] [Google Scholar]
- 11.Yamashita, T., Hashiramoto, A., Haluzik, M., Mizukami, H., Beck, S., Norton, A., Kono, M., Tsuji, S., Daniotti, J. L., Werth, N., Sandhoff, R., Sandhoff, K., and Proia, R. L. (2003) Proc. Natl. Acad. Sci. U. S. A. 100 3445-3449 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Yoon, S. J., Nakayama, K., Hikita, T., Handa, K., and Hakomori, S. I. (2006) Proc. Natl. Acad. Sci. U. S. A. 103 18987-18991 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Popko, B. (2000) Glia 29 149-153 [DOI] [PubMed] [Google Scholar]
- 14.Susuki, K., Baba, H., Tohyama, K., Kanai, K., Kuwabara, S., Hirata, K., Furukawa, K., Rasband, M. N., and Yuki, N. (2007) Glia 55 746-757 [DOI] [PubMed] [Google Scholar]
- 15.Liu, Y., Wada, R., Kawai, H., Sango, K., Deng, C., Tai, T., McDonald, M. P., Araujo, K., Crawley, J. N., Bierfreund, U., Sandhoff, K., Suzuki, K., and Proia, R. L. (1999) J. Clin. Investig. 103 497-505 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Hellbusch, C. C., Sperandio, M., Frommhold, D., Yakubenia, S., Wild, M. K., Popovici, D., Vestweber, D., Grone, H. J., von Figura, K., Lubke, T., and Korner, C. (2007) J. Biol. Chem. 282 10762-10772 [DOI] [PubMed] [Google Scholar]
- 17.Sandhoff, R., Hepbildikler, S. T., Jennemann, R., Geyer, R., Gieselmann, V., Proia, R. L., Wiegandt, H., and Grone, H. J. (2002) J. Biol. Chem. 277 20386-20398 [DOI] [PubMed] [Google Scholar]
- 18.Jennemann, R., Sandhoff, R., Wang, S., Kiss, E., Gretz, N., Zuliani, C., Martin-Villalba, A., Jager, R., Schorle, H., Kenzelmann, M., Bonrouhi, M., Wiegandt, H., and Grone, H. J. (2005) Proc. Natl. Acad. Sci. U. S. A. 102 12459-12464 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Jennemann, R., Sandhoff, R., Langbein, L., Kaden, S., Rothermel, U., Gallala, H., Sandhoff, K., Wiegandt, H., and Grone, H. J. (2007) J. Biol. Chem. 282 3083-3094 [DOI] [PubMed] [Google Scholar]
- 20.Neville, D. C., Coquard, V., Priestman, D. A., te Vruchte, D. J., Sillence, D. J., Dwek, R. A., Platt, F. M., and Butters, T. D. (2004) Anal. Biochem. 331 275-282 [DOI] [PubMed] [Google Scholar]
- 21.Gorgas, K., and Krisans, S. K. (1989) J. Lipid Res. 30 1859-1875 [PubMed] [Google Scholar]
- 22.Chomczynski, P., and Sacchi, N. (1987) Anal. Biochem. 162 156-159 [DOI] [PubMed] [Google Scholar]
- 23.Adams, J., Kiss, E., Arroyo, A. B., Bonrouhi, M., Sun, Q., Li, Z., Gretz, N., Schnitger, A., Zouboulis, C. C., Wiesel, M., Wagner, J., Nelson, P. J., and Grone, H. J. (2005) Am. J. Pathol. 167 285-298 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Livak, K. J., and Schmittgen, T. D. (2001) Methods (San Diego) 25 402-408 [DOI] [PubMed] [Google Scholar]
- 25.Ohta, H., Yomogida, K., Dohmae, K., and Nishimune, Y. (2000) Development (Camb.) 127 2125-2131 [DOI] [PubMed] [Google Scholar]
- 26.Oakberg, E. F. (1956) Am. J. Anat. 99 507-516 [DOI] [PubMed] [Google Scholar]
- 27.Nebel, B. R., Amarose, A. P., and Hacket, E. M. (1961) Science 134 832-833 [DOI] [PubMed] [Google Scholar]
- 28.Bellve, A. R., Cavicchia, J. C., Millette, C. F., O'Brien, D. A., Bhatnagar, Y. M., and Dym, M. (1977) J. Cell Biol. 74 68-85 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Sutcliffe, M. J., and Burgoyne, P. S. (1989) Development (Camb.) 107 373-380 [DOI] [PubMed] [Google Scholar]
- 30.Ward-Bailey, P. F., Johnson, K. R., Handel, M. A., Harris, B. S., and Davisson, M. T. (1996) Mamm. Genome 7 793-797 [DOI] [PubMed] [Google Scholar]
- 31.Knudson, C. M., Tung, K. S., Tourtellotte, W. G., Brown, G. A., and Korsmeyer, S. J. (1995) Science 270 96-99 [DOI] [PubMed] [Google Scholar]
- 32.Nantel, F., Monaco, L., Foulkes, N. S., Masquilier, D., LeMeur, M., Henriksen, K., Dierich, A., Parvinen, M., and Sassone-Corsi, P. (1996) Nature 380 159-162 [DOI] [PubMed] [Google Scholar]
- 33.Blendy, J. A., Kaestner, K. H., Weinbauer, G. F., Nieschlag, E., and Schutz, G. (1996) Nature 380 162-165 [DOI] [PubMed] [Google Scholar]
- 34.Furland, N. E., Oresti, G. M., Antollini, S. S., Venturino, A., Maldonado, E. N., and Aveldano, M. I. (2007) J. Biol. Chem. 282 18151-18161 [DOI] [PubMed] [Google Scholar]
- 35.Furland, N. E., Zanetti, S. R., Oresti, G. M., Maldonado, E. N., and Aveldano, M. I. (2007) J. Biol. Chem. 282 18141-18150 [DOI] [PubMed] [Google Scholar]
- 36.Walden, C. M., Sandhoff, R., Chuang, C. C., Yildiz, Y., Butters, T. D., Dwek, R. A., Platt, F. M., and van der Spoel, A. C. (2007) J. Biol. Chem. 282 32655-32664 [DOI] [PubMed] [Google Scholar]
- 37.Lee, N. P., Mruk, D. D., Xia, W., and Cheng, C. Y. (2007) J. Endocrinol. 192 17-32 [DOI] [PubMed] [Google Scholar]
- 38.Mizutani, Y., Kihara, A., and Igarashi, Y. (2006) Biochem. J. 398 531-538 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Lahiri, S., and Futerman, A. H. (2005) J. Biol. Chem. 280 33735-33738 [DOI] [PubMed] [Google Scholar]
- 40.Mizutani, Y., Kihara, A., and Igarashi, Y. (2005) Biochem. J. 390 263-271 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Grogan, W. M., and Lam, J. W. (1982) Lipids 17 604-611 [DOI] [PubMed] [Google Scholar]
- 42.Ishizuka, I., Suzuki, M., and Yamakawa, T. (1973) J. Biochem. (Tokyo) 73 77-87 [PubMed] [Google Scholar]
- 43.Suzuki, A., Ishizuka, I., Ueta, N., and Yamakawa, T. (1973) Jpn. J. Exp. Med. 43 435-442 [PubMed] [Google Scholar]
- 44.Ishizuka, I. (1997) Prog. Lipid Res. 36 245-319 [DOI] [PubMed] [Google Scholar]
- 45.Riebeling, C., Allegood, J. C., Wang, E., Merrill, A. H., Jr., and Futerman, A. H. (2003) J. Biol. Chem. 278 43452-43459 [DOI] [PubMed] [Google Scholar]
- 46.Svennerholm, L. (1994) Prog. Brain Res. 101 XI-XIV [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.